Herberts, Cameron

$1,100.00 CAD

Department
Canadian Institutes of Health Research
Program
Recipient country
Canada
Fiscal year
2018-2019
Agreement period
October 1, 2018 – September 30, 2019
Reference
cihr-irsc:236-2018-2019-Q3-00565

Published purpose

Circulating tumor DNA (ctDNA) profiling reveals a deficiency of biomarkers predictive of docetaxel response in patients with metastatic castration-resistant prostate cancer (mCRPC).

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions